Researcher Who Studied Benefits Of Red Wine Falsified Data Says University
http://www.medicalnewstoday.com/articles/240222.php
An extensive misconduct investigation that took three years to complete and produced a 60,000-page report, concludes that a researcher who has come to prominence in recent years for his investigations into the beneficial properties of resveratrol, a compound found in red wine, is guilty of 145 counts of fabrication and falsification of data.
In a statement published on the universitys news website on Wednesday, the University of Connecticut (UConn) Health Center said the investigation has led them to inform 11 scientific journals that had published studies conducted by Dr Dipak K. Das, a professor in the unversitys Department of Surgery and director of its Cardiovascular Research Center.
The internal investigation, which covered seven years of work in Dass lab, was triggered by an anonyomous allegation of research irregularities in 2008.
Philip Austin, UConns interim vice president for health affairs, said:
We have a responsibility to correct the scientific record and inform peer researchers across the country.
According to a report from the Associated Press (AP), Dr Nir Barzilai, whose team conducts resveratrol research at the Albert Einstein College of Medicine in New York, says Das is not a major player in the field.
Barzilai told AP lots of labs around the world are conducting extensive research into resveratrol, with encouraging results, and the new allegation will not make a material difference.
